Cited by 276Diabetes, Cardiovascular Risks, and LipoproteinsAcute Myocardial Infarction ResearchHealthcare Systems and Public Health

The DOI matches its Crossref record, with a small difference in title or year; 39 of the 40 references it cites were found in a registry or an index.

Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction

Lee, Chong Do, Folsom, Aaron R., Pankow, James S., Brancati, Frederick L.·2004·Circulation

DOI 10.1161/01.cir.0000116389.61864.de

Open this paper in CoChat — free account

Abstract

Background— Whether diabetic patients without a history of myocardial infarction (MI) have the same risk of coronary heart disease (CHD) events as nondiabetic patients with a history of MI remains controversial. We compared risks of CHD and stroke events and mortality from cardiovascular disease (CVD) in diabetic and nondiabetic men and women with and without a history of MI. Methods and Results— We followed a total of 13 790 African American and white men and women ages 45 to 64 years who participated in the Atherosclerosis Risk in Communities study, beginning in 1987 to 1989. There were 634 fatal CHD or nonfatal MI events, 312 fatal or nonfatal strokes, and 358 deaths from CVD during an average of 9 years of follow-up (125 998 person-years). After adjustment for age, sex, race, Atherosclerosis Risk in Communities field center, and multiple baseline risk factors, patients who had a history of MI without diabetes at baseline had 1.9 times the risk of fatal CHD or nonfatal MI (95% CI, 1.35 to 2.56; P <0.001) compared with diabetic patients without a prior history of MI. The nondiabetic patients with MI also had 1.8 times the risk of CVD mortality compared with diabetic patients without MI (95% CI, 1.22 to 2.72; P =0.003). However, stroke risk was similar between diabetic patients without MI and nondiabetic patients with MI (RR, 1.05; 95% CI, 0.61 to 1.79; P =0.87). We also observed that nondiabetic patients with MI had a carotid artery wall thickness similar to diabetic patients without MI ( P =0.77). Conclusions— Diabetic patients without MI had lower risk of CHD events and mortality from CVD compared with nondiabetic patients with MI, but stroke risk was similar between these 2 groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000116389.61864.de

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 3,510

Show all 40 references

Research works printed but not linked: 8

10.1161/circ.100.10.1134 · DOI
10.1161/circ.97.18.1837 · DOI
10.1001/jama.1988.03410230074031 · DOI
Geiss LS Herman WH Smith PJ. Mortality in non-insulin-dependent diabetes. In: National Diabetes Data Group ed. Diabetes in America. Bethesda Md: US Department of Health and Human Services Public Health Service National Institutes of Health; 1995: 233–257.
1982, Clin Chem, 28, 1574.
10.1161/str.30.4.736 · DOI
10.1161/circ.102.9.1014 · DOI
10.1161/atv91.12.6.1591228 · DOI

Sorted by citations

Items 101–200 of 275

Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell
Liao, Y.-F., Feng, Y., Chen, L., Zeng, T., Fan, Y., & Hu, L. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.09.009 · Cited by 26
Normotensive Women With Type 2 Diabetes and Microalbuminuria Are at High Risk for Macrovascular Disease
Zandbergen, A. A. M., Sijbrands, E. J. G., Lamberts, S. W. J., & Bootsma, A. H. (2006) · Diabetes Care · doi:10.2337/dc06-0287 · Cited by 26
The burden of hyperlipidaemia and diabetes in cardiovascular diseases
Merkler, M., & Reiner, Ž. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00529.x · Cited by 26
Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites
Zhu, J., Bao, Z., Hu, Z., Wu, S., Tian, C., Zhou, Y., Ding, Z., & Tan, X. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00268-4 · Cited by 28
Biological Surrogates for Enhancing Cardiovascular Risk Prediction in Type 2 Diabetes Mellitus
Clair, L. S., & Ballantyne, C. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.008 · Cited by 24
Coronary heart disease and cardiovascular autonomic neuropathy in the elderly diabetic
Chanudet, X., Bonnevie, L., & Bauduceau, B. (2007) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)80054-1 · Cited by 24
Identification and Predictors for Cardiovascular Disease Risk Equivalents Among Adults With Diabetes
Zhao, Y., Malik, S., Budoff, M. J., Correa, A., Ashley, K. E., Selvin, E., Watson, K. E., & Wong, N. D. (2021) · Diabetes Care · doi:10.2337/dc21-0431 · Cited by 23
Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability
Pan, C. Y., & Wang (2013) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s30071 · Cited by 25
Stem cells in the diabetic infarcted heart
Glass, C. E., Singal, P. K., & Singla, D. K. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9172-8 · Cited by 22
Diabetes and cardiovascular events in high-risk patients: Insights from a multicenter registry in a middle-income country
Schaan, B. D., Neto, J. A. D. F., Moreira, L. B., Ledur, P. D. S., Mattos, L. A., Magnoni, D., Précoma, D. B., Machado, C. A., Brasileiro, A. L. D. S., Pena, F. M., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.021 · Cited by 22
Is Diabetes Mellitus a Coronary Heart Disease Equivalent? Results of a Meta-Analysis of Prospective Studies
González-Clemente, J. M., Palma, S., Arroyo, J., Vilardell, C., Caixàs, A., Giménez‐Palop, O., & Delgado‐Rodríguez, M. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60047-x · Cited by 21
Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes ― A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society ―
Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., Ishii, H., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0865 · Cited by 24
Risk Functions and the Primary Prevention of Cardiovascular Disease
Grau, M., & Marrugat, J. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60141-3 · Cited by 21
Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
Groenewegen, A., Zwartkruis, V. W., Cekic, B., de Boer, R. A., Rienstra, M., Hoes, A. W., Rutten, F. H., & Hollander, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01313-7 · Cited by 21
High prevalence of cardiovascular disease in South Asians: Central role for brown adipose tissue?
Boon, M. R., Bakker, L. E. H., van der Linden, R. A. D., van Ouwerkerk, A. F., de Goeje, P. L., Counotte, J., Jazet, I. M., & Rensen, P. C. N. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.1003634 · Cited by 20
Different prognostic value of silent peripheral artery disease in type 2 diabetic and non-diabetic subjects with stable cardiovascular disease
Mostaza, J. M., Manzano, L., Suárez, C., Fernández, C., de Enterría, M. M. G., Tirado, R., Nicolás, F., & Sanchez-Zamorano, M. A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.020 · Cited by 19
Cardiovascular comorbidities among public health clinic patients with diabetes: the Urban Diabetics Study
Robbins, J. M., Webb, D. A., & Sciamanna, C. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-15 · Cited by 19
Telemedicine Home Blood Pressure Measurements and Progression of Albuminuria in Elderly People With Diabetes
Palmas, W., Pickering, T. G., Teresi, J. A., Schwartz, J. E., Field, L., Weinstock, R. S., & Shea, S. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108589 · Cited by 19
Increased carotid intima-media thickness in the physiologic range is associated with impaired postprandial glucose metabolism, insulin resistance and beta cell dysfunction
Andreozzi, F., Gastaldelli, A., Mannino, G. C., Sciacqua, A., Succurro, E., Arturi, F., Folli, F. B., & Perticone, F. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.028 · Cited by 18
Coronary risk equivalence of diabetes assessed by SPECT-MPI
Morales, D. C., Bhavnani, S. P., Ahlberg, A. W., Pullatt, R. C., Katten, D. M., Polk, D. M., & Heller, G. V. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1114-6 · Cited by 18
Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective
Cubbon, R. M., Kahn, M., & Kearney, M. T. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01646.x · Cited by 18
The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study
Gorter, P. M., Visseren, F. L. J., Algra, A., van der Graaf, Y., & on behalf of the SMART Study Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02323.x · Cited by 18
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design
the EMPA-ICD investigators, Fujiki, S., Iijima, K., Okabe, M., Niwano, S., Tsujita, K., Naito, S., Andò, K., KUSANO, K. F., Kato, R., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00924-9 · Cited by 17
Di-peptidyl peptidase-4 inhibitor sitagliptin protects vascular function in metabolic syndrome: possible role of epigenetic regulation
Çiçek, F. A., Zeynep, T.-K., Özçınar, E., Bozkuş, Y., Can, A. K., & Belma, T. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3392-2 · Cited by 17
Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society
the directors of the JCS, J., Araki, E., Tanaka, A., Inagaki, N., Ito, H., Ueki, K., Murohara, T., Imai, K., Sata, M., Sugiyama, T., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00471-5 · Cited by 16
Cardiovascular Ischemic Event Rates in Outpatients With Symptomatic Atherothrombosis or Risk Factors in the United States
Eagle, K. A., Hirsch, A. T., Califf, R. M., Alberts, M. J., Steg, P. G., Cannon, C. P., Brennan, D. M., & Bhatt, D. L. (2009) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e3181a84613 · Cited by 17
Isolated Type 2 Diabetes mellitus Causes Myocardial Dysfunction That Becomes Worse in the Presence of Cardiovascular Diseases: Results of the Myocardial Doppler in Diabetes (MYDID) Study 1
Govind, S. C., Brodin, L., Nowak, J., Quintana, M., Raumina, S., Ramesh, S. S., Keshava, R., & Saha, S. K. (2005) · Cardiology · doi:10.1159/000085126 · Cited by 17
Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review
Moralidis, E., Didangelos, T., Arsos, G. A., Athyros, V. G., & Mikhailidis, D. P. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1098 · Cited by 16
Screening for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus
Tavares, C. A. F., Wajchjenberg, B. L., Rochitte, C. E., & Lerário, A. C. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000170 · Cited by 18
Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus
Kazemian, P., Wexler, D. J., Fields, N. F., Parker, R. A., Zheng, A., & Walensky, R. P. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0393 · Cited by 16
Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease
Dagenais, G. R., St-Pierre, A., Gilbert, P., Lamarche, B., Després, J., Bernard, P., & Bogaty, P. M. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.071027 · Cited by 16
Complications of Diabetes Mellitus
Brownlee, M., Aiello, L. P., Cooper, M. E., Vinik, A. I., Nesto, R. W., & Boulton, A. J. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00033-x · Cited by 16
Are diabetic patients at increased risk of arrhythmias?
Nakou, E. S., Mavrakis, H. E., & Vardas, P. E. (2012) · PubMed · Cited by 16
Detecting DNA synthesis of neointimal formation after catheter balloon injury in GK and in Wistar rats: using 5-ethynyl-2'-deoxyuridine
Guo, J., Li, D., Bai, S., Xu, T., Zhou, Z., & Zhang, Y. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-150 · Cited by 15
Coronary risk prediction for those with and without diabetes
(2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200602000-00005 · Cited by 15
How to revascularize patients with diabetes mellitus—
Elsässer, A., Möllmann, H., NEF, H. M., & Hamm, C. W. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0365-z · Cited by 15
Prevención primaria con estatinas, consensos y tablas de riesgo
García, F. M., Ortiz, A. G., & Alonso, M. (2005) · Atención Primaria · doi:10.1157/13075929 · Cited by 15
Management of diabetes in cardiovascular patients
Peter, R., Cox, A., & Evans, M. (2008) · Heart · doi:10.1136/hrt.2006.098210 · Cited by 15
Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: A study from the Western Denmark Heart Registry
Gyldenkerne, C., Olesen, K. K. W., Thrane, P. G., Madsen, M., Thim, T., Würtz, M., Jensen, L. O., Raungaard, B., Poulsen, P. L., Bøtker, H. E., et al. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120941809 · Cited by 14
Perspectives of patients with type 2 diabetes following a critical cardiac event – an interpretative approach
Wu, C.-J. J., Chang, A. M., & McDowell, J. (2007) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2006.01926.x · Cited by 14
Reducing cardiovascular disease in patients with diabetes mellitus
Mazzone, T. (2005) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000166598.29464.20 · Cited by 13
The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention
Benjamin, B. K., Qiu, C., Han, Z., Lu, W., Sun, G., Qin, X., Wang, X., Wang, X., Li, R., & Pan, L. (2021) · Journal of Diabetes Research · doi:10.1155/2021/7580486 · Cited by 12
Audit of patients with type 2 diabetes following a critical cardiac event
Wu, C.-J. J., & Chang, A. M. (2008) · International Nursing Review · doi:10.1111/j.1466-7657.2008.00636.x · Cited by 12
Correlation of the severity of diabetic retinopathy and the heart muscle perfusion in patients with type 2 diabetes
Tryniszewski, W., Kuśmierczyk, J., Maziarz, Z., Goś, R., Mikhailidis, D. P., Banach, M., Rysz, J., & Pesudovs, K. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.02.003 · Cited by 11
Riesgo cardiovascular en diabetes mellitus e hipertensión arterial en España. Estudio CORONARIA
Aguilar, J. A. C., Padial, L. R., Martínez, A. H., Urrestarazu, R. A., Morell, X. M., Peláez, B. A., Llopis, A. A., & Gómez, J. L. Z. (2006) · Medicina Clínica · doi:10.1157/13090381 · Cited by 11
Impact of chronic kidney disease and end-stage renal disease on the mid-term adverse outcomes in diabetic patients with cardiovascular diseases
Chou, C., Chiu, H., Hsu, Y., Yu, S. M.-W., Liou, T., & Sung, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-66655-0 · Cited by 10
Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus
Findeisen, H. M., Weckbach, S., Stark, R. G., Reiser, M. F., Schoenberg, S. O., & Parhofer, K. G. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-44 · Cited by 9
Cardiovascular risk stratification in diabetic patients
Petretta, M., Acampa, W., Fiumara, G., & Cuocolo, A. (2013) · Clinical and Translational Imaging · doi:10.1007/s40336-013-0032-0 · Cited by 11
Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease
Gyldenkerne, C., Olesen, K. K. W., Madsen, M., Thim, T., Jensen, L. O., Raungaard, B., Sørensen, H. T., Bøtker, H. E., & Mæng, M. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119836227 · Cited by 10
Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus
Hovens, M. M. C., Tamsma, J. T., Beishuizen, E. D., & Huisman, M. V. (2005) · Drugs · doi:10.2165/00003495-200565040-00001 · Cited by 10
Clinical implications of carotid artery intima media thickness assessment on cardiovascular risk stratification in hyperlipidemic Korean adults with diabetes: the ALTO study
Hong, E., Ohn, J. H., Lee, S. J., Kwon, H., Kim, S. G., Kim, D. J., & Kim, D. S. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0109-y · Cited by 9
Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus
Patel, N. B., & Balady, G. J. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9129-1 · Cited by 9
Prevalence of multiple cardiac risk factors in US adults with diabetes
McCollum, M., Ellis, S. L., Morrato, E. H., & Sullivan, P. W. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x104894 · Cited by 9
The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population
Jung, C. H., Seo, G. H., Suh, S., Bae, J. C., Kim, M. K., Hwang, Y., Kim, J. H., & Lee, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128627 · Cited by 8
Lipoprotein Metabolism and the Treatment of Lipid Disorders
Freeman, M. W., & Walford, G. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00041-x · Cited by 10
La prevención cardiovascular en la diabetes mellitus: un reto multifactorial
Pedro‐Botet, J., Chillarón, J. J., Benaiges, D., & Roux, J. A. F. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.10.003 · Cited by 9
Guidelines for the Clinical Application of Bypass Grafts and the Surgical Techniques (JCS 2011) Published in 2012
JCS Joint Working Group (2013) · Circulation Journal · doi:10.1253/circj.cj-66-0066 · Cited by 8
Epaisseur de l’intima-média carotidienne et facteurs de risque cardio-vasculaires
Herinirina, N. F., Ny, L. H., Herijoelison, A. R., & Ahmad, A. (2015) · Pan African Medical Journal · doi:10.11604/pamj.2015.21.153.6876 · Cited by 8
Manejo de las dislipemias en poblaciones especiales: tratamiento de la dislipemia diabética
Vila, C. L. (2005) · Atención Primaria · doi:10.1016/s0212-6567(05)70584-9 · Cited by 8
Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus
Purga, S. L., Sidhu, M. S., Farkouh, M. E., & Schulman‐Marcus, J. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6750-1 · Cited by 7
Diabetes and 15-year Cardiovascular Mortality in a Chinese Population: Differential Impact of Hypertension and Metabolic Syndrome
Chuang, S., Hsu, P., Sung, S., Chou, P., & Chen, C.-H. (2010) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(10)70051-4 · Cited by 7
Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen
Chillarón, J. J. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i9.415 · Cited by 7
Diabetes mellitus y calidad de vida en población geriátrica institucionalizada
Álaba, J. (2007) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(07)73583-7 · Cited by 7
How to identify patients with vulnerable plaques
Virani, S. S., & Ballantyne, C. M. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00812.x · Cited by 7
The association of long‐acting insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: A population‐based cohort study
Brunetti, V. C., Yu, O. H. Y., Platt, R. W., & Filion, K. B. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14802 · Cited by 6
Cardiovascular disease
Le, N. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f20df8 · Cited by 6
Effects of a myocardial ischaemia-guided therapeutic program on survival and incidence of coronary events in asymptomatic patients with diabetes: the ARCADIA study
Vanzetto, G., Boizel, R., Halimi, S., Ormezzano, O., Belle, L., Fagret, D., & Machecourt, J. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.06.006 · Cited by 6
[Diabetes mellitus and coronary artery disease--a high risk combination]
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2006) · Clinical Research in Cardiology · Cited by 6
Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis
Singh, S., Loke, Y. K., & Furberg, C. D. (2007) · JAMA · doi:10.1001/jama.298.10.1189 · Cited by 5
Update on diabetic kidney disease
Rico-Fontalvo, J. E., Jiménez, L. C. V., Yánez, T. R., Daza-Arnedo, R., Raad-Sarabia, M., Hernández, J. D. M., Vargas, M. L., & Quintero, J. J. (2022) · Anales de la Facultad de Ciencias Médicas (Asunción) · doi:10.18004/anales/2022.055.03.86 · Cited by 5
Effect of Nurse-Led Individualised Self-Care Model on Myocardial Infarction Patients with Diabetes: A Randomised Controlled Pilot Trial
Zhang, J., Zhou, X., Qian, K.-K., Yu, J.-D., He, H., Zhao, L.-H., Yang, W.-W., Geng, G., & Shen, H. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2401031 · Cited by 6
Chronic treatment with losartan (angiotensin II type 1 receptor antagonist) normalizes enhanced acetylcholine-induced coronary vasoconstriction in isolated perfused hearts of type 2 diabetic OLETF rats
Matsumoto, T., Ozawa, Y., Taguchi, K., Kobayashi, T., & Kamata, K. (2009) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.45.197 · Cited by 5
Antiplatelet therapy for primary prevention in diabetes
Ambrosi, P., Villani, P., & Bouvenot, G. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(06)70487-6 · Cited by 5
Endothelial dysfunction and intima media thickness are selectively related to the different carbohydrate disturbances across the glucose continuum
Gateva, A., Assyov, Y. S., Gatev, T., & Kamenov, Z. A. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1479762 · Cited by 5
Diabetes mellitus und koronare Herzkrankheit
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-1115-y · Cited by 5
Effect of Hypertension on the Carotid Artery Intima Media Thickness (IMT) in Patients with Type 2 Diabetes Mellitus - Across Sectional Study
AL-Auqbi, T. F. R., Al-Sabbagh, A. A., Al-Karawi, I. N., & Bahrani, M. A. J. (2014) · Cited by 5
An Italian Chart for Cardiovascular Risk Estimate Including High-Density Lipoprotein-Cholesterol
Menotti, A., & Lanti, M. (2008) · Disease Management & Health Outcomes · doi:10.2165/00115677-200816030-00005 · Cited by 5
Cardiovascular events in patients with over 10 years history of type 2 diabetes mellitus
Saed, L., Deihim, Z., Naghshbandi, M. K., Rajabnia, M., & Naleini, S. N. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.08.026 · Cited by 4
Implications of the global diabetes epidemic
Steiner, G. A. (2006) · Diabetes and Vascular Disease Research · doi:10.1177/147916410600300102 · Cited by 4
Practical aspects of the control of cardiovascular risk in type 2 diabetes mellitus and the metabolic syndrome.
Cerghizan, A., Bala, C. G., Niţă, C., & Hâncu, N. (2007) · PubMed Central · Cited by 4
Estimation of cardiovascular risk and detection of subclinical carotid atheromatosis in patients with diabetes without a history of cardiovascular disease
Masson, W. M., Francesca, S. D., Molinero, M., Siniawski, D. A., Mulassi, A. H., Espinoza‐Morales, F., Huerin, M. S., Lobo, M., & Molinero, G. B. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000234 · Cited by 4
Cardiología preventiva y rehabilitación
Ligorit, A. D. R. (2006) · Revista Española de Cardiología · doi:10.1157/13084448 · Cited by 4
Association of MRI Left Atrial Strain With Ischemic Stroke in Myocardial Infarction Patients
Chen, L., Chen, W., Liu, J., Du, X., Lu, Y., & Che, W. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29833 · Cited by 3
The Role of Revascularization Versus Medical Therapy in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Page, B. J., Kireyev, D., & Boden, W. E. (2010) · Current Diabetes Reports · doi:10.1007/s11892-009-0091-9 · Cited by 3
Morbimortalidad por cardiopatía isquémica en el paciente diabético
Esteve, E., & Ricart, W. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71123-8 · Cited by 3
Today's guidance
Mansfield, M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.1424-4.x · Cited by 3
Carotid intima-media thickness and its associations with type 2 diabetes mellitus in South Africans
Rheeder, P., Duim-Beytell, M. C., Meijer, R., Gustavsson, T., Danler, G., Ahmed, R., & Zyl, D. G. V. (2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872292 · Cited by 3
Insuffisance coronaire, cardiomyopathie et neuropathie autonome chez le diabétique
Chanudet, X., Chenilleau, M.-C., Schiano, P., & Bauduceau, B. (2008) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(08)48491-3 · Cited by 3
NHG-Standaard Cardiovasculair risicomanagement
Boukes, F., Geijer, R. M. M., Opstelten, W., Wiersma, T., & Goudswaard, A. N. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_20 · Cited by 3
Macrovascular Disease in Diabetes
Bilous, F. R., & Donnelly, R. (2010) · Wiley eBooks · doi:10.1002/9781444391374.ch20 · Cited by 3
Coronary artery disease in diabetes: which (if any) test is best?
Lauer, M. S. (2005) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.72.1.6 · Cited by 3
Management of type 2 diabetes mellitus and prediction of cardiovascular complications
van Dieren, S., Health, C., Health, J. O. C., Economics, E. &. H., van der Schouw, Y. T., Beulens, J. W. J., & Peelen, L. M. (2013) · Utrecht University Repository (Utrecht University) · Cited by 3
Transit time flow management as a management strategy in high-risk groups undergoing coronary artery bypass grafting
Kucera, J. A., Duggan, J. P., Peters, A., & Trachiotis, G. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03408-8 · Cited by 2
Dislipemia diabética, síndrome metabólico y riesgo cardiovascular
Otero, I. G., & González‐Juanatey, J. R. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)75325-0 · Cited by 2
Review: Cardiovascular risk and diabetes in old people
Rodríguez‐Mañas, L., Castro, M., & Arámbarri, J. M. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050010201 · Cited by 2
Prise en charge de l’hypertension artérielle chez le patient diabétique
Mignot, A., Sosner, P., Llaty, P., & Herpin, D. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74745-5 · Cited by 2
Glucose influence on copper ion-dependent oxidation of low density lipoprotein.
Ghaffari, M. A., & Mojab, S. (2009) · PubMed · Cited by 2
Features of the risk profile of patients with type 2 diabetes and/or cardiovascular disease in a primary care centre in Barcelona (Spain)
Canivell, S., Ortiz, J., Mitjavila, J., Otero, X., Sotoca, J., & Gomis, R. (2012) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2012.06.001 · Cited by 2
Effects of Abscisic Acid on the Diabetic Changes in Rat Myocardium
Samir, S. M., moustafa, A., & mahdy, M. (2019) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2018.4308.1003 · Cited by 2
Evaluation of cardiovascular risk according to framingham tables in a colombian population
Pereira-Rodríguez, J. E., Rogelio, D. S., Noelly, S. R. K., Griselda, R. L., Johanna, G.-S., Flórez, D. G. P., & Lorena, B. M. (2019) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2019.12.00420 · Cited by 2

Authors: Lee, C. D., Folsom, A. R., Pankow, J. S., & Brancati, F. L.
Affiliations: University of Minnesota (US)
ORCID: Folsom, Aaron R.
Pankow, James S.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-02-24
Volume: 109
Issue: 7
Pages: 855-860
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000116389.61864.de
OpenAlex: W2089154533
Cited by: 276
References: 40
Citations by year: 2026: 3 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 7 · 2019: 9 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 10 · 2014: 9 · 2013: 10 · 2012: 16
FWCI: 18.67
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc55021-47-0-1, n01hc55020-39-0-0, n01hc55016-37-0-0, n01hc055022-024, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc55015-48-0-1)
National Heart, Lung, and Blood Institute (N01-HC55022, N01-HC-55018, N01 HC 55020, N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022, N01 HC 55019, N01-HC55016, N01‐HC‐55015, N01-HC55021, T32 HL07779, HL07779, T32HL007779)
National Institute of Diabetes and Digestive and Kidney Diseases (1K24 DK 6222-01, N01-HC-55016, N01-HC-55018, N01-HC-55021, N01-HC-55020, N01-HC-55015, N01-HC-55019, N01-HC-55022)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Keywords: diabetes mellitus, myocardial infarction, coronary artery disease, stroke, cardiovascular mortality, cardiovascular risk, carotid intima-media thickness, African American adults, Atherosclerosis Risk in Communities Study
MeSH terms: Black or African American, Cardiovascular Diseases, Carotid Arteries, Diabetes Mellitus, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hypertension, Male, Middle Aged, Myocardial Infarction, Obesity, Risk, Smoking, Ultrasonography, United States, Cohort Studies, Comorbidity, Life Tables, Survival Analysis, Tunica Intima, Tunica Media, Stroke, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks